SU

Pharmacokinetics - Repeat Dose Administration Notes

Recap of PK Parameters
  • Key PK parameters: K{el}, t{1/2}, F, V, CL; determined after a single dose.

Steady State Concentration (Css)
  • Steady state: drug entering plasma equals clearance from plasma.

  • Therapeutic window: Plasma drug concentration between MEC and MTC.

Continuous Dosing Methods
  • Repeat oral administration & Constant rate IV infusion.

Constant Rate IV Infusion
  • Predict Desired Css and Time to reach Css.

  • CSS = \frac{MDR}{CL}; MDR = maintenance dose rate.

  • Time to steady state: 3-5 half-lives.

  • Loading dose (DL): DL = Css \times V

Repeat Oral Administration
  • CSS = \frac{F \times MDR}{CL}, F = absolute oral bioavailability.

  • Dosing interval (\tau) determines concentration variation between C{max ss} and C{min ss}.

  • C*{max} = \frac{Dose \times F}{V}

Equations
  • C{max ss} = \frac{F \cdot Dose}{V \cdot (1-e^{-K{el} \cdot \tau})}

  • C{min ss} = C{max ss} \cdot e^{-K[el} \cdot \tau}

  • Css = mean : of : C{min ss} : and : C{max ss}

General Rules for Dosing Regimens
  • t[1/2} < 30 min: difficult to maintain therapeutic concentrations.

  • t[1/2} 30 min - 8 h: dosing based on therapeutic window and convenience.

  • t[1/2} 8 h - 24 h: dose every half-life.

  • t[1/2} > 24 h: once per day or several days dosing feasible, but delayed Css.

Pharmacist’s Perspective
  • Pharmacists select from manufacturer supplies, applying dosing principles.

  • Drug strengths affect Css, and dosing period impacts drug concentrations.

Summary of PK Parameters
  • t[1/2}: time to reach steady state.

  • CL: concentration at steady state (Css).

  • V: loading dose and first oral dose.

  • F: with CL, Css following oral dosing.

  • K{el}: variability in concentrations; C{max} relative to therapeutic window.

Design of Oral Dosing Regimens
  • Balances t[1/2}, therapeutic window, drug concentration variability, time to steady state, and dosing period convenience.